Nasdaq
$0.6500▲ 0.78%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $31.4MShares out 48.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
12- 5d agoPre-market26.10.20 21:178-KKey event#●●●
FILANA THERAPEUTICS, INC.Bullish
The U.S. Court of Appeals for the Fifth Circuit has vacated the class certification order in the securities class action against Filana Therapeutics. The court accepted the company's argument that the lower court failed to properly evaluate evidence regarding market inefficiency, and further proceedings on class certification will now take place in the Texas District Court.…more
$0.6500+0.78%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.1Pre-market26.10.01 20:574Ownership
FILANA THERAPEUTICS, INC.
Filana Therapeutics, Inc. insider Barry Richard filed a Form 4 on October 1, 2026, regarding a change in beneficial ownership of securities effective September 29, 2026. This filing serves as an official notification to the SEC regarding the insider's equity transaction.…more
$0.6500+0.78%vs prev closeView filingShare - 9.30After-hours26.10.01 05:034Ownership
FILANA THERAPEUTICS, INC.
Insider Barry Richard of Filana Therapeutics, Inc. reported a change in beneficial ownership of securities effective September 28, 2026. This filing serves as the official disclosure of the insider's equity transaction via Form 4.…more
$0.6500+0.78%vs prev closeView filingShare
11 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoPre-market26.10.20 21:22#●●●
Filana Therapeutics Wins Appeal on Class Certification Ruling
The Fifth Circuit Court of Appeals ruled that the Texas District Court misapplied the legal standard regarding class certification. This decision provides a favorable legal development for the company by addressing potential litigation risks.…more
$0.6500+0.78%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.9Pre-market26.10.09 21:00
●●●●●●●● ●●●●● ●●●●●●
Filana Therapeutics announced that its management team will attend the 2026 Maxim Growth Summit to conduct one-on-one meetings with investors. This participation serves as a corporate outreach event and does not involve any new material contracts or financial results.…more
$0.6500+0.78%vs prev close - 9.22Regular26.09.23 01:47
●●●●●●●● ●●●●● ●●●●●●
The FDA has lifted the clinical hold on Filana Therapeutics' investigational new drug application, allowing the company to proceed with its Phase 2a trial. The company expects to begin screening patients for the epilepsy study by the first quarter of 2027.…more
$0.6500+0.78%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report